SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001819790-23-000018
Filing Date
2023-04-26
Accepted
2023-04-26 17:02:56
Documents
3
Period of Report
2023-04-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_168254296286561.html 3  
1 FORM 3 wf-form3_168254296286561.xml 3 1774
2 JEFFREY FARROW POA farrowpoa-exhibit24.htm EX-24 4183
3 GRAPHIC farrowpoa-exhibit24001.jpg GRAPHIC 236007
  Complete submission text file 0001819790-23-000018.txt   332472
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Farrow Jeffrey S (Reporting) CIK: 0001405253 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39614 | Film No.: 23850643

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)